Receptor desensitization
pharmacologyA rapid loss of a receptor's responsiveness while an agonist is still bound, produced by phosphorylation — typically by G-protein-coupled receptor kinases — that uncouples the receptor from its signalling partners. It is the first step in a sequence that also includes internalisation and downregulation, and it reverses on a far shorter timescale than the loss of receptors themselves.
Receptor desensitization is the process by which a receptor becomes temporarily unresponsive to its activating signal even while a drug or neurotransmitter remains bound to it. The receptor is still occupied but has been functionally silenced — its connection to the intracellular machinery that carries its signal has been severed.
It is the earliest and most reversible stage in a broader adaptive sequence. After desensitization, continued stimulation can lead to the receptor being drawn inside the cell (internalisation) and, over longer timescales, to the cell producing fewer receptors overall (downregulation). Desensitization itself reverses within minutes to hours; the later stages take considerably longer.
How it works · its role
The classical mechanism operates at G-protein-coupled receptors (GPCRs) — a large family that includes opioid, cannabinoid, serotonin, and dopamine receptors among many others. When such a receptor is activated, enzymes called G-protein-coupled receptor kinases (GRKs) attach phosphate groups to its intracellular surface.
This phosphorylation creates a docking site for proteins called arrestins. Arrestin binding physically displaces the G-protein that normally carries the receptor's signal downstream. The receptor can still be occupied by the agonist, but it can no longer pass the signal on.
Once arrestin attaches, it also flags the receptor for endocytosis — the cell draws the receptor into a vesicle and carries it inward. There it can be recycled back to the surface, resetting sensitivity, or sent for degradation, which contributes to longer-term downregulation.
Relevance to substances & effects
Opioid receptors — particularly the mu-opioid receptor — are among the most studied examples. Continuous opioid exposure triggers rapid desensitization, and this partly explains why the felt effects of a steady dose fade faster than the drug clears: the receptors remain occupied but are no longer signalling at full strength.
Cannabinoid CB1 receptors follow a similar pattern, contributing to the tolerance many regular cannabis users notice over days of consistent use.
For serotonergic psychedelics, desensitization of the 5-HT₂A serotonin receptor is thought to underlie their unusually fast tolerance. Because the receptor desensitises quickly under repeated stimulation, a second dose taken within roughly one to two days produces substantially weaker effects than the first — even at a comparable concentration.
Tolerance & dependence
Receptor desensitization is one molecular basis for tachyphylaxis — the rapid fading of effect within a single exposure or across closely spaced doses. Because desensitization can reverse relatively quickly once stimulation stops, this layer of tolerance often resolves within hours to a few days, depending on the receptor system involved.
The slower stages of the same process — internalisation and downregulation — account for tolerance that persists over weeks of regular use. Recovery from those changes is correspondingly slower. This layered timescale helps explain why some substance tolerance lifts with a short break while other forms require sustained abstinence before sensitivity is meaningfully restored.
AI-generated · not yet verified by a human reviewer
Harm-reduction reference — not medical advice.